MedCity News

APRIL 18, 2025

If the nations top public health agency pulls support of vaccination, other healthcare stakeholders will need to step up to fill the vaccine messaging void. Kennedy Jr.s rise to become secretary of the Department of Health and Human Services has some concerned that anti-vaccine policies are coming.

Healthcare 303

Healthcare Healthcare FDA Physicians 303

MedCity News

NOVEMBER 10, 2024

By fostering collaboration and seamless data integration into healthcare systems, the industry is laying the groundwork for a future in which “personalized medicine” is so commonplace within clinical practice that we will just start calling it “medicine.”

Patients 311

Patients Medicine Healthcare Healthcare 311

MedCity News

JULY 31, 2024

Here is a selection of recent executive hires, retirements, promotions and layoffs occurring across the healthcare industry. The post Healthcare Moves: A Monthly Summary of Hires and Layoffs appeared first on MedCity News.

Healthcare 278

Healthcare Healthcare Medicine Biopharma 278

Fierce Pharma

JANUARY 8, 2024

Biopharma companies looking to maximize the visibility of their M&A activity often reveal deals during the J.P. Morgan Healthcare Conference. | In it’s annual Firepower report, EY says the biopharma industry enters 2024 with the capability and motivation to increase M&A activity.

Prospecting 224

Prospecting Biopharma Pharma Healthcare 224

MedCity News

JANUARY 14, 2025

Morgan Healthcare Conference, Lilly CEO David Ricks explained why the company revised downward its projections for fourth quarter 2024 revenue. Revenue for the blockbuster Eli Lilly drugs Mounjaro and Zepbound continues to grow, but not as much as expected. At the J.P.

Sales 290

Sales Healthcare Healthcare Biopharma 290

MedCity News

NOVEMBER 26, 2024

While advanced analytics and AI can unlock unprecedented insights, it’s the thoughtful application of these insights that transforms routine interactions between pharmaceutical representatives and healthcare providers into lasting relationships.

Healthcare Provider 298

Healthcare Provider Pharmaceutical Healthcare Healthcare 298

MedCity News

NOVEMBER 20, 2024

We cannot change the fact that some patients must take multiple drugs, but we can certainly change how we manage it with careful coordination and communication among healthcare providers, and personalized medicine practices such as pharmacogenomics.

Management 297

Management Medical Healthcare Provider Medicine 297

MedCity News

NOVEMBER 3, 2024

As multi-billion investment continues to pour into the R&D of future obesity medications, the need for evidence generation of health benefits beyond short-term weight loss will be critical to the decision-making of healthcare providers and payers. The post Redefining Clinical Development of Obesity Drugs: What Does Success Look Like?

Healthcare Provider 289

Healthcare Provider Healthcare Healthcare Medical 289

Fierce Pharma

JUNE 11, 2024

Amid a recent biopharma M&A resurgence, one major player plans to stay out of the waters after making multiple recent splashes.

Biopharma 265

Biopharma Healthcare Healthcare 265

MedCity News

AUGUST 27, 2023

We can apply this approach in pharma by enhancing our patient journey maps and go beyond focusing on the key clinical engagement touch points (e.g., doctor visits, prescription pickups) and enriching our insights with the micro-moments surrounding these obvious events.

Healthcare 242

Healthcare Healthcare Prescription Doctors 242

MedCity News

JANUARY 11, 2023

Morgan Healthcare Conference in San Francisco, Paul Hudson said unlike Sanofi, large pharma companies with top-selling drugs have a portfolio akin to a leaky bathtub because in a few years, they will have to replace much of that revenue as drug patents expire. In a media briefing during the J.P.

Media 321

Media Pharma Healthcare Healthcare 321

Fierce Pharma

OCTOBER 3, 2024

Matthew Walsh, General Manager of Biopharma at ixlayer - the leading cloud-based platform powering an end-to-end, direct-to-patient healthcare solution - sat down with Fierce at Digital Phar | Matthew Walsh, General Manager of Biopharma at Ixlayer – a cloud-based platform specialist empowering operational efficiency, patient access, and improved outcomes (..)

Patients 130

Patients Biopharma Management Pharma 130

World of DTC Marketing

JUNE 7, 2021

The true risk to pharma in response to unacceptable drug pricing may come from growing bipartisan support to increase industry antitrust scrutiny and penalties. If enacted, the bill would mean many proposed biopharma deals would be presumed to be anti-competitive , with an obligation on the sponsors to disprove. AARP Drug Pricing.

Pharma 187

Pharma Retail Competition Prescription 187

Fierce Pharma

SEPTEMBER 19, 2023

Artificial intelligence (AI) has enormous potential in healthcare, but all too often, it gets misunderstood. With the right infrastructure, intelligent tools stand to not only process data but also improve clinical decision-making—helping find more patients for biopharma companies, and faster, too.

Biopharma 207

Biopharma Healthcare Healthcare Patients 207

European Pharmaceutical Review

JULY 7, 2023

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.

Competition 104

Competition Biopharma Government Manufacturing 104

Fierce Pharma

JUNE 11, 2024

braces for a potential government shake-up ahead of its general election next month, the country’s premier biopharma trade organization is throwing down the gauntlet. | political parties to blueprint their plans to unlock the nation’s healthcare industry potential, according to a press release issued Monday. As the U.K.

Biopharma 182

Biopharma Government Healthcare Healthcare 182

Fierce Pharma

FEBRUARY 27, 2024

A seismic shift has occurred in the healthcare landscape. Delivering on these heightened expectations has fueled the urgency to invest in patient engagement and support.

Biopharma 170

Biopharma Patients Healthcare Healthcare 170

European Pharmaceutical Review

SEPTEMBER 15, 2023

For its 20 th anniversary, more than 180 entries across 12 categories have been narrowed down to determine the finalists the upcoming CPHI Pharma Awards. To recognise the influx of innovation across the pharmaceutical industry, three new categories are included in this year’s awards.

Pharma 119

Pharma Manufacturing Biopharma Pharmaceutical 119

MedCity News

SEPTEMBER 8, 2022

Alira Health hopes its purchase of RedCrow will help it stand out from the crowd of consulting firms that help life sciences companies bring drugs to market.

Consulting 278

Consulting Healthcare Healthcare Marketing 278

MedCity News

SEPTEMBER 15, 2024

To realize true, sustainable savings in total cost of care, the healthcare system needs to reconsider the support — or lack of support — it provides throughout patients’ medication experiences and the snowball effect that creates on a lifetime of healthcare costs.

Medical 295

Medical Healthcare Healthcare Patients 295

MedCity News

JULY 29, 2024

As the FDA stakes its claim as the primary regulator of AI in healthcare, it must navigate the delicate balance between fostering innovation and ensuring safety and responsibility. The post Enabling Clinical Trial Innovation Through AI Regulation at FDA appeared first on MedCity News.

FDA 317

FDA Safety Healthcare Healthcare 317

PharmExec

JUNE 21, 2023

Biopharma aims to strengthen field engagement with healthcare professionals.

Biopharma 98

Biopharma Pharma Healthcare Healthcare 98

MedCity News

OCTOBER 3, 2024

The Hippocratic oath can’t stop with direct patient care; the healthcare industry and its key stakeholders must address persistent public health problems systematically. We have the tools to reduce medication harm by half or more; it is long past time to make this a public health priority.

Medical 321

Medical Healthcare Healthcare Patients 321

Eversana Intouch

NOVEMBER 9, 2023

Back in 2003, drugs from large pharma companies made up 36% of the late-stage R&D pipeline. These data are astonishing, given the perception that Big Pharma is the main driver of biopharma innovation. Yet, we know small-to-mid-sized pharma launches face a unique set of challenges. Not anymore.

Pharma 105

Pharma Biopharma Competition Marketing 105

Pharmaceutical Technology

JUNE 24, 2022

invoX Pharma has signed a definitive agreement for the acquisition of all issued and outstanding shares of clinical-stage biopharma firm F-star Therapeutics, in a deal valued at nearly $161m or $7.12 invoX Pharma is a fully owned Sino Biopharmaceutical subsidiary. for each share in cash.

Biopharma 64

Biopharma Pharma Pharmacology Healthcare 64

MedCity News

JANUARY 15, 2024

Morgan Healthcare Conference, CEO Joshua Brumm said Dyne’s existing cash combined with the new capital is expected to last through 2025—well beyond the next key milestones for both therapeutic candidates. Dyne Therapeutics recently reported encouraging Phase 1/2 clinical data in myotonic dystrophy type 1 and Duchenne muscular dystrophy.

Medicine 305

Medicine Healthcare Healthcare Biopharma 305

MedCity News

JANUARY 9, 2024

Morgan Healthcare Conference in San Francisco. Though GSK divested much of its oncology assets to Novartis in 2015, the company has built it back through a internal R&D and business development deals.

Healthcare 306

Healthcare Healthcare Biopharma Pharma 306

MedCity News

OCTOBER 23, 2024

For patients who may be unable to afford the high cost of GLP-1 obesity drugs or are worried about the side effects, it’s important for healthcare providers to offer education on herbal alternatives and consider these as part of the broader treatment conversation. appeared first on MedCity News.

Side effects 304

Side effects Healthcare Provider Education Healthcare 304

Pharma Marketing Network

MARCH 25, 2022

With an estimated 65 million people serving as caregivers, 1 the role is now a factor in an ever-increasing list of healthcare priorities. If caregiving is positioned as an essential service and caregivers are counted among healthcare’s front-line service providers, 4 does it follow caregivers are a viable healthcare vertical?

Pharma 98

Pharma Education Training Transportation 98

pharmaphorum

DECEMBER 18, 2022

However, most models are based on an old-fashioned and expensive call centre-based approach that fails to meet the needs of patients and healthcare providers (HCPs) as consumers. Yet, the healthcare experience is antiquated. entertainment or consumer apps), before it is production-worthy for mission-critical healthcare applications.

Biopharma 98

Biopharma Patients Prescription Medical 98

MedCity News

JANUARY 25, 2023

As healthcare organizations comply with the federal EPCS mandate, artificial intelligence and digital identity technologies should be utilized to detect, reduce, and remediate drug diversion.

Healthcare 290

Healthcare Healthcare Electronics Prescription 290

European Pharmaceutical Review

JANUARY 12, 2023

Out of 19 companies honoured with the 2022 Terra Carta Seal, the three pharma companies awarded were: GlaxoSmithKline PLC. ” Biopharma successful in achieving climate-related goals, report finds. The post 2022 Terra Carta Seal: three pharma companies awarded appeared first on European Pharmaceutical Review.

Pharma 105

Pharma Biopharma Manufacturing Government 105

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. The post Chiesi expands rare disease portfolio with Amryt Pharma acquisition appeared first on. in an all-cash transaction at $14.50 per American Depositary Share (ADS). on 6 th January.

Pharma 98

Pharma Biopharma Management Medicine 98

pharmaphorum

NOVEMBER 28, 2022

Amidst all this, Adelphi Group’s CEO Stuart Cooper found a moment to sit with pharmaphorum web editor Nicole Raleigh and discuss just how exciting it was to bring to vibrant and discursive life the ethos of Anthropy – a united vision for British business, including pharma, and the future of this nation overall.

Pharma 98

Pharma Biopharma Recruitment Management 98

MedCity News

NOVEMBER 22, 2023

Innovations in healthcare and technology are reshaping the specialty pharmacy onboarding process. Embracing digital technologies, connected ecosystems, automation, and longitudinal reporting can eliminate paperwork, accelerate processes and provide data-driven insights for continuous improvement.

Medical 264

Medical Healthcare Healthcare Biopharma 264

pharmaphorum

OCTOBER 11, 2022

The Reuters Pharma event 2022 began as a bustling industry affair yesterday, based out of the Nice Acropolis convention centre on France’s balmy south coast. The onus, he said, was on pharma to listen now. Patient engagement – what history teaches us about pharma’s future evolution. Maximising potential, inspiring in pharma.

Pharma 98

Pharma Patients Medicine Healthcare 98

MedCity News

JULY 13, 2023

Clinicians say over-the-counter availability will lower barriers to access to a key component of reproductive healthcare. FDA approval of Opill makes it the first oral contraceptive that may be used without a prescription.

FDA 246

FDA Prescription Healthcare Healthcare 246